Cartitude-5: A Randomized, Phase 3 Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Not Intended for Transplant

Details

Language :

English

ISSN :

26666375 and 26666367

Volume :

28

Issue :

3, Number 3 Supplement 1

Database :

Supplemental Index

Journal :

Transplantation and Cellular Therapy

Publication Type :

Periodical

Accession number :

ejs59182803

Full Text :

https://doi.org/10.1016/S2666-6367(22)00381-5